Artha Sootra - Company Dashboard

Governance Classic Home

Aarti Pharmalabs LtdPharmaceuticalsINE0LRU01027Consolidated₹926.75+7.15 (+0.78%)

Valuation

Market Cap₹8.40K Cr

TTM PE32.73x

Forward PE30.19x

PEG1.60

Book Value₹248.65

P/B3.73x

TTM EPS₹28.31

Fwd EPS₹30.69

TTM Revenue₹2.16K Cr

TTM PAT₹256.69 Cr

TTM EBITDA₹486.72 Cr

TTM EBIT₹369.38 Cr

Last Qtr PAT₹71.47 Cr

Last Qtr EBITDA₹135.16 Cr

Last Qtr EBIT₹104.63 Cr

Profitability

ROE11.38%

ROCE11.84%

TTM NPM11.88%

TTM EBITDA %22.52%

Curr OPM11.70%

Last OPM14.20%

Curr NPM—

Last NPM—

Curr EPS₹7.88

Last EPS₹8.40

Balance sheet

Equity₹45.34 Cr

Reserve₹2.21K Cr

Total Debt₹897.13 Cr

D/E0.40x

Interest %20.92%

Curr Interest₹14.95 Cr

Price / range

Close₹926.50

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.71%

1W+5.35%

1M-4.09%

3M+34.56%

6M+15.02%

1Y+9.72%

2Y+42.56%

3Y+137.41%

5Y—

Diwali+24.55%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	612.59+46.8%	534.59	579.70	425.25	417.29	1,797.55
Other Income	0.47	2.93	10.53	-0.37	3.15	15.32
Total Income	613.05+45.8%	537.52	590.23	424.88	420.44	1,812.87
Interest	14.95	12.87	16.86	12.58	10.66	46.90
Expenditure	-521.74-37.8%	-441.30	-507.65	-363.51	-378.74	-1,575.84
PBDT	0	0	0	0	0	0
EBITDA	136.33+84.3%	136.19	117.07	102.94	73.98	372.91
Depreciation	-30.53	-30.03	-28.16	-28.62	-24.77	-104.30
EBIT	105.80+115.0%	106.16	88.91	74.32	49.21	268.61
PBT	89.27+114.1%	96.22	82.59	58.58	41.70	234.24
Tax	-23.52	-24.92	-20.55	-14.74	-10.77	-58.04
Equity	45.34	45.34	45.33	45.33	0	45.33
OPM	14.56	17.90	13.99	13.79	9.99	12.92
Net Profit	65.75+112.6%	71.31	62.03	43.84	30.93	176.20
NPM	10.73	13.27	10.51	10.32	7.41	9.72
EPS	7.25+112.6%	7.87	6.84	4.84	3.41	19.44

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	1,797.55+1.5%	1,771.35+17.9%	1,502.13-0.6%	1,511.25
Other Income	15.32	14.49	11.01	1.28
Total Income	1,812.87+1.5%	1,785.84+18.0%	1,513.14+0.0%	1,512.53
Expenditure	-1,575.84-8.7%	-1,449.50-17.0%	-1,238.62+3.2%	-1,279.17
Interest	-46.90	-25.63	-16.64	-20.48
PBDT	0	0	0	0
EBITDA	372.91-12.6%	426.54+23.2%	346.16+12.3%	308.33
Depreciation	-104.30	-79.06	-66.01	-55.77
EBIT	268.61-22.7%	347.48+24.0%	280.15+10.9%	252.56
PBT	234.24-30.4%	336.34+22.5%	274.52+17.6%	233.36
Tax	-58.04	-78.99	-73.87	-61.63
Equity	45.33	45.32	0	0
OPM (%)	12.92	18.83	18.00	15.00
Net Profit	176.20-31.5%	257.35+28.3%	200.65+16.8%	171.73
NPM (%)	9.72	14.41	13.00	11.00
EPS (Rs)	19.44-31.5%	28.39+28.2%	22.14+16.8%	18.95
CEPS	19.42	28.38	22.14	18.85

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	610.45+45.9%	535.80	582.64	432.27	418.34	1,819.44
Other Income	0.47	0.45	8.05	-0.37	0.05	9.75
Total Income	610.92+46.0%	536.25	590.70	431.90	418.39	1,829.19
Interest	14.95	12.88	16.86	12.58	10.67	46.90
Expenditure	-520.77-37.4%	-442.59	-514.53	-371.16	-379.05	-1,601.47
PBDT	0	0	0	0	0	0
EBITDA	135.16+80.9%	136.12	113.13	102.31	74.73	369.21
Depreciation	-30.53	-30.03	-28.16	-28.62	-24.77	-104.34
EBIT	104.63+109.4%	106.09	84.97	73.69	49.96	264.87
PBT	88.11+124.0%	93.65	76.17	57.95	39.34	224.92
Tax	-23.52	-24.92	-20.55	-14.91	-10.77	-58.21
Equity	45.34	45.34	45.33	45.32	0	45.33
OPM	14.42	17.46	12.89	13.42	9.40	12.30
Net Profit	71.47+156.0%	76.14	61.12	47.96	27.92	174.71
NPM	11.70	14.20	10.35	11.10	6.67	9.55
EPS	7.88+155.8%	8.40	6.74	5.29	3.08	19.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	1,819.44-14.0%	2,115.07+14.2%	1,852.61-4.8%	1,945.23
Other Income	9.75	10.12	4.90	2.32
Total Income	1,829.19-13.9%	2,125.19+14.4%	1,857.50-4.6%	1,947.55
Expenditure	-1,601.47+9.2%	-1,764.50-13.3%	-1,557.01+7.7%	-1,686.78
Interest	-46.90	-26.90	-17.21	-21.05
PBDT	0	0	0	0
EBITDA	369.21-20.5%	464.37+20.3%	386.05+12.9%	342.04
Depreciation	-104.34	-86.90	-73.24	-62.54
EBIT	264.87-29.8%	377.47+20.7%	312.81+11.9%	279.50
PBT	224.92-37.6%	360.69+20.0%	300.49+15.2%	260.77
Tax	-58.21	-88.28	-83.59	-67.28
Equity	45.33	45.32	0	0
OPM (%)	12.30	16.97	16.18	13.39
Net Profit	174.71-35.9%	272.40+25.6%	216.90+12.1%	193.49
NPM (%)	9.55	12.82	11.68	9.94
EPS (Rs)	19.27-35.9%	30.06+25.6%	23.93+12.1%	21.35
CEPS	19.25	30.04	23.93	21.35

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	2	15 Sep 2026
2026	Interim Dividend	1.5	16 Feb 2026
2025	Final Dividend	2.5	15 Sep 2025
2025	Interim Dividend	2.5	14 Feb 2025
2024	Final Dividend	1	31 Jul 2024
2024	Interim Dividend	2	16 Feb 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split